Yongxiang Zhao

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Venues

Signal transduction and targeted therapy

Nature biomedical engineering

Science advances

Advanced materials (Deerfield Beach, Fla.)

This page only lists publications with an associated author ORCID identifier.

Publications

Minghui Yang, Chunhui Li, Guoguo Ye, Chenguang Shen, Huiping Shi, Liping Zhong, Yuxin Tian, Mengyuan Zhao, Pengfei Wu, Abid Hussain, Tian Zhang, Haiyin Yang, Jun Yang, Yuhua Weng, Xinyue Liu, Zhimin Wang, Lu Gan, Qianyu Zhang, Ying-Xia Liu, Ge Yang, Yuanyu Huang, Yongxiang Zhao
Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity. Signal transduction and targeted therapy 9 (1) (2024)
Minghui Yang, Chunhui Li, Guoguo Ye, Chenguang Shen, Huiping Shi, Liping Zhong, Yuxin Tian, Mengyuan Zhao, Pengfei Wu, Abid Hussain, Tian Zhang, Haiyin Yang, Jun Yang, Yuhua Weng, Xinyue Liu, Zhimin Wang, Lu Gan, Qianyu Zhang, Ying-Xia Liu, Ge Yang, Yuanyu Huang, Yongxiang Zhao
Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity. Signal transduction and targeted therapy 9 (1) (2024)
Minghui Yang, Chunhui Li, Guoguo Ye, Chenguang Shen, Huiping Shi, Liping Zhong, Yuxin Tian, Mengyuan Zhao, Pengfei Wu, Abid Hussain, Tian Zhang, Haiyin Yang, Jun Yang, Yuhua Weng, Xinyue Liu, Zhimin Wang, Lu Gan, Qianyu Zhang, Ying-Xia Liu, Ge Yang, Yuanyu Huang, Yongxiang Zhao
Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity. Signal transduction and targeted therapy 9 (1) (2024)
Chenya Wang, Liping Zhong, Jiachen Xu, Qi Zhuang, Fei Gong, Xiaojing Chen, Huiquan Tao, Cong Hu, Fuquan Huang, Nailin Yang, Junyan Li, Qi Zhao, Xinjun Sun, Yu Huo, Qian Chen, Yongxiang Zhao, Rui Peng, Zhuang Liu
Oncolytic mineralized bacteria as potent locally administered immunotherapeutics. Nature biomedical engineering (2024)
Chenya Wang, Liping Zhong, Jiachen Xu, Qi Zhuang, Fei Gong, Xiaojing Chen, Huiquan Tao, Cong Hu, Fuquan Huang, Nailin Yang, Junyan Li, Qi Zhao, Xinjun Sun, Yu Huo, Qian Chen, Yongxiang Zhao, Rui Peng, Zhuang Liu
Oncolytic mineralized bacteria as potent locally administered immunotherapeutics. Nature biomedical engineering 8 (5) (2024)
Chenya Wang, Liping Zhong, Jiachen Xu, Qi Zhuang, Fei Gong, Xiaojing Chen, Huiquan Tao, Cong Hu, Fuquan Huang, Nailin Yang, Junyan Li, Qi Zhao, Xinjun Sun, Yu Huo, Qian Chen, Yongxiang Zhao, Rui Peng, Zhuang Liu
Oncolytic mineralized bacteria as potent locally administered immunotherapeutics. Nature biomedical engineering (2024)
Minghui Yang, Chunhui Li, Guoguo Ye, Chenguang Shen, Huiping Shi, Liping Zhong, Yuxin Tian, Mengyuan Zhao, Pengfei Wu, Abid Hussain, Tian Zhang, Haiyin Yang, Jun Yang, Yuhua Weng, Xinyue Liu, Zhimin Wang, Lu Gan, Qianyu Zhang, Ying-Xia Liu, Ge Yang, Yuanyu Huang, Yongxiang Zhao
Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity. Signal transduction and targeted therapy 9 (1) (2024)
Chenya Wang, Liping Zhong, Jiachen Xu, Qi Zhuang, Fei Gong, Xiaojing Chen, Huiquan Tao, Cong Hu, Fuquan Huang, Nailin Yang, Junyan Li, Qi Zhao, Xinjun Sun, Yu Huo, Qian Chen, Yongxiang Zhao, Rui Peng, Zhuang Liu
Oncolytic mineralized bacteria as potent locally administered immunotherapeutics. Nature biomedical engineering 8 (5) (2024)
Changyu Cao, Tingbo Zhang, Nan Yang, Xianghong Niu, Zhaobo Zhou, Jinlan Wang, Dongliang Yang, Peng Chen, Liping Zhong, Xiaochen Dong, Yongxiang Zhao
Correction To: POD Nanozyme optimized by charge separation engineering for light/pH activated bacteria catalytic/photodynamic therapy. Signal transduction and targeted therapy 8 (1) (2023)
Bo Hu, Bo Li, Kun Li, Yuanyuan Liu, Chunhui Li, Lulu Zheng, Mengjie Zhang, Tongren Yang, Shuai Guo, Xiyu Dong, Tian Zhang, Qing Liu, Abid Hussain, Yuhua Weng, Ling Peng, Yongxiang Zhao, Xing-Jie Liang, Yuanyu Huang
Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia. Science advances 8 (7) (2022)
Zhikun Zhang, Yongxiang Zhao
Progress on the roles of MEF2C in neuropsychiatric diseases. Molecular brain 15 (1) (2022)
Yong Huang, Liping Zhong, Xiaotong Li, Pan Wu, Jian He, Chao Tang, Zhiping Tang, Jing Su, Zhenbo Feng, Bing Wang, Yun Ma, Hongmei Peng, Zhihao Bai, Yi Zhong, Ying Liang, Wenxi Lu, Ruiyu Luo, Jinghua Li, Haiping Li, Zhiming Deng, Xianli Lan, Ziqun Liu, Kun Zhang, Yongxiang Zhao
In Situ Silver-Based Electrochemical Oncolytic Bioreactor. Advanced materials (Deerfield Beach, Fla.) 34 (40) (2022)
Changyu Cao, Tingbo Zhang, Nan Yang, Xianghong Niu, Zhaobo Zhou, Jinlan Wang, Dongliang Yang, Peng Chen, Liping Zhong, Xiaochen Dong, Yongxiang Zhao
POD Nanozyme optimized by charge separation engineering for light/pH activated bacteria catalytic/photodynamic therapy. Signal transduction and targeted therapy 7 (1) (2022)
Liping Zhong, Yong Huang, Jian He, Nuo Yang, Banghao Xu, Yun Ma, Junjie Liu, Chao Tang, Chengpiao Luo, Pan Wu, Zongqiang Lai, Yu Huo, Tao Lu, Dongni Huang, Wenlin Gong, Lu Gan, Yiqun Luo, Zhikun Zhang, Xiyu Liu, Yongxiang Zhao
Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver. Signal transduction and targeted therapy 6 (1) (2021)
Jing Chen, Xue Wang, Yuan Yuan, Haoting Chen, Lingpu Zhang, Haihua Xiao, Jingqi Chen, Yongxiang Zhao, Jin Chang, Weisheng Guo, Xing-Jie Liang
Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair-inhibiting (HYDRI) nanomedicine. Science advances 7 (13) (2021)
Yongchao Wang, Ningqiang Gong, Chi Ma, Yuxuan Zhang, Hong Tan, Guangchao Qing, Jimei Zhang, Yufei Wang, Jinjin Wang, Shizhu Chen, Xianlei Li, Qiankun Ni, Yuan Yuan, Yaling Gan, Junge Chen, Fangzhou Li, Jinchao Zhang, Caiwen Ou, Yongxiang Zhao, Xiaoxuan Liu, Xing-Jie Liang
An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination. Nature communications 12 (1) (2021)
Ge Yang, Ziyue Li, Irfan Mohammed, Liping Zhao, Wei Wei, Haihua Xiao, Weisheng Guo, Yongxiang Zhao, Feng Qu, Yuanyu Huang
Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1. Signal transduction and targeted therapy 6 (1) (2021)
Yingying Huang, Sufang Zhou, Yong Huang, Duo Zheng, Qiqi Mao, Jian He, Yiwei Wang, Dabing Xue, Xiaoling Lu, Nuo Yang, Yongxiang Zhao
Isolation of Fibroblast-Activation Protein-Specific Cancer-Associated Fibroblasts. BioMed research international 2017 (2017)

Yongxiang Zhao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yongxiang Zhao